Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CD40 Ligand antibody: Phase I Update

Biogen Inc. (BGEN), Cambridge, Mass.
Product: CD40

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE